VITAMIN A (100,000 IU) AND VITAMIN E (20 IU) ORAL LIQUID PREPARATION CAPSULE

País: Canadá

Idioma: inglés

Fuente: Health Canada

Ingredientes activos:

VITAMIN A (RETINYL PALMITATE); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)

Disponible desde:

NUTRICORP INTERNATIONAL

Código ATC:

A11JA

Designación común internacional (DCI):

COMBINATIONS OF VITAMINS

Dosis:

100000UNIT; 20UNIT

formulario farmacéutico:

CAPSULE

Composición:

VITAMIN A (RETINYL PALMITATE) 100000UNIT; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 20UNIT

Vía de administración:

ORAL

Unidades en paquete:

500

tipo de receta:

Prescription

Área terapéutica:

VITAMIN A

Resumen del producto:

Active ingredient group (AIG) number: 0225696006; AHFS:

Estado de Autorización:

APPROVED

Fecha de autorización:

2016-04-06

Ficha técnica

_ _
_Page 1 of 34_
PRODUCT MONOGRAPH
PR
VITAMIN A (100,000 IU) AND VITAMIN E (20 IU) ORAL LIQUID PREPARATION
VITAMIN A AND VITAMIN E SOFTGEL CAPSULES
100,000 IU Vitamin A (all-trans-retinyl palmitate) and 20 IU Vitamin E
(all-rac-alpha-
tocopheryl acetate)
One IU of Vitamin A is equivalent to the activity of 0.3 mcg of
all-trans-retinol
ATC code: Vitamins – A11
Nutricorp International
4025 Rhodes Drive
Windsor, Ontario
N8W 5B5
Date of Preparation:
April 5, 2016
Submission Control No: 167923
_ _
_ _
_Page 2 of 34_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................4
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................5
DRUG INTERACTIONS
....................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................7
OVERDOSAGE
..................................................................................................................8
ACTION AND CLINICAL PHARMACOLOGY
..............................................................9
STORAGE AND STABILITY
..........................................................................................12
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................12
PART II: SCIENTIFIC INFORMATION
...............................................................................14
PHARMACEUTICAL INFORMATION
.......................................................